RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
146 hedge funds and large institutions have $2.31B invested in Ra Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 71 funds opening new positions, 29 increasing their positions, 36 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+27
Holders Change %
+22.69%
% of All Funds
2.88%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
71
Increased
29
Reduced
36
Closed
44
Calls
$4.4M
Puts
$22.1M
Net Calls
-$17.7M
Net Calls Change
-$17.6M
Top Buyers
| 1 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$99.3M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$89.5M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$86.3M |
| 4 |
Citigroup
New York
|
+$79.5M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$55.8M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$190M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$53M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$51.8M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$33.4M |
| 5 |
First Manhattan
New York
|
-$32.5M |
